EDIT Q1 2023 Earnings — Editas Medicine, Inc. Revenue & Financial Results | Market Cap Arena

EDITEditas Medicine, Inc.

$256M

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$10M+45.5% YoY

Gross Profit

-$28M-283.8% margin

Operating Income

-$51M-517.3% margin

Net Income

-$49M-497.8% margin

EPS (Diluted)

$-0.66

QoQ Revenue Growth

+50.7%

Cash Flow

Operating Cash Flow

-$36M

Free Cash Flow

-$38M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$464M

Total Liabilities

$147M

Stockholders' Equity

$317M

Cash & Equivalents

$129M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$7M	+45.5%
Gross Profit	-$28M	-$31M	+10.4%
Operating Income	-$51M	-$51M	-0.4%
Net Income	-$49M	-$51M	+2.9%